Unlike pills, injections provide a more direct way to deliver medication, which can result in more consistent and effective outcomes
Where the benefit is included, prior authorization is required: typically BMI 30 or higher, or BMI 27 or higher with a weight-related comorbidity (hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea), plus documented lifestyle program participation and weight-loss maintenance for renewal
Published literature describes GHK and GHK-Cu as being involved in tissue repair, fibroblast activity, angiogenesis, and collagen/elastin-related biological processes
In these studies, participants using a 2.4 mg weekly dose of semaglutide, alongside lifestyle interventions, lost an average of about 15% of their initial body weight over 68 weeks
Didangelos T, Karlafti E, Kotzakioulafi E, et al